Hepatitis C
Conditions
Keywords
Motivational Interviewing, Healthcare delivery
Brief summary
This study addresses a difficult barrier to hepatitis C elimination, specifically development and maintenance of a productive relationship between the health care provider and patient to ensure both treatment success and engagement in harm reduction services. Improvements in these domains may be observed through the use of a technique called Motivational Interviewing (MI). The aim of this study is to determine whether a customized motivational interviewing curriculum by general primary care and addictions medicine primary care providers changes rates of curative hepatitis C therapy completion.
Interventions
Motivational Interviewing is a directive, client-centered counselling style intended to elicit behavior change by helping patients reach health goals through their own desires and actions. A certified and experienced Motivational Interviewing trainer will develop and deliver the curriculum to healthcare providers.
Sponsors
Study design
Eligibility
Inclusion criteria
Patient Inclusion Criteria: * Willingness to participate and provide informed consent * Positive HCV RNA Result * ≥18 years of age Patient
Exclusion criteria
* Unwilling or unable to provide consent Health Care Provider Inclusion Criteria: * Willingness to participate and provide informed consent * Has a hepatitis C care experience Health Care Provider
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| HCV Treatment Completion | Through study completion, an average of 2 years | To measure the number of patients who complete HCV therapy |
Secondary
| Measure | Time frame |
|---|---|
| Number of unique Hepatitis C related and unrelated health system visits | Through study completion, an average of 2 years |
| Number of scheduled and attended medical care appointments | Through study completion, an average of 2 years |
| Self-reported intent to initiate and maintain HCV treatment assessed by questionnaire | Through study completion, an average of 2 years |
| Time from care engagement to treatment initiation | Through study completion, an average of 2 years |
| Time to complete prescribed HCV treatment course | Through study completion, an average of 2 years |
| Percentage of eligible individuals that initiate HCV therapy | Through study completion, an average of 2 years |
| Healthcare provider knowledge, attitudes, and behavior about motivational interviewing and training assessed by questionnaire | Through study completion, an average of 2 years |
Countries
Canada